SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2009-03-31
Filing Date Changed: 2009-05-07
Documents: 5

SEC Accession No.
0001193125-09-103623
Filing date: 2009-05-07
Accepted: 2009-05-07 17:30:57

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	d10q.htm	1313790	FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009
2	EX-31.1	dex311.htm	12340	CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302
3	EX-31.2	dex312.htm	12311	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER SECTION 302
4	EX-32.1	dex321.htm	3322	CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 906
5	EX-32.2	dex322.htm	3360	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER SECTION 906

		0001193125-09-103623.txt	1347187	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 09806894
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-126922 | Film No.: 09806892
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060